|
- Home Page: American Journal of Ophthalmology
AJO Case Reports Opens in new window is the online-only open access companion journal to the AJO exclusively devoted to the publication of case reports, case series and brief reports AJO International Opens in new window is committed to fostering a global and international exchange of knowledge within the field of ophthalmology and visual science
- Current Issue Table of Contents: American Journal of Ophthalmology
Explore the latest research, reviews, and updates in ophthalmology from the American Journal of Ophthalmology's current issue
- List of Issues - American Journal of Ophthalmology
An issue that is "In Progress" contains final, fully citable articles that are published online but the issue is awaiting more articles before it can be considered "final " Individual article details such as volume, issue and page numbers will not change
- Articles in Press: American Journal of Ophthalmology
Please select at least one article in order to proceed
- National Trends in Central Retinal Artery Occlusion Presentations and . . .
Central retinal artery occlusion (CRAO) is a medical emergency that presents as an acute painless vision loss and can be a harbinger of an impending stroke A prompt stroke workup upon diagnosis and admission to the emergency department (ED) is crucial since the 48 hours following CRAO present the highest risk of stroke; as high as 30% rate of acute ischemic stroke on magnetic resonance
- What the American Journal of Ophthalmology Wants to Publish
To aid in your writing, submission, and reviewing processes, we have prepared the following 6 questions that the AJO Editorial Board addresses when determining if a full-length article is appropriate for the Journal:
- Comment on: Intraocular lens power calculation—comparing big data . . .
We would like to commend Redden et al1 for their insightful study, “Intraocular Lens Power Calculation—Comparing Big Data Approaches to Established Formulas,” published in the Journal Their comparative evaluation of big data approaches against traditional intraocular lens (IOL) power calculation formulas is a significant contribution to literature The study highlights the potential of
- Agreement Between Color, Fluorescein Angiography, and Spectral Domain . . .
The standard of care for neovascular age-related macular degeneration (nAMD), which is vascular endothelial growth factor (VEGF) inhibitor therapy, has transformed the treatment landscape for this condition A number of biologicals -ranibizumab, aflibercept,1 brolucizumab, and faricimab- arrived in quick succession with subsequent approval by regulatory agencies throughout the world for the
|
|
|